A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA

<strong>Background:</strong> The West African outbreak of Ebola virus disease that peaked in 2014 has caused more than 11,000 deaths. The development of an effective Ebola vaccine is a priority for control of a future outbreak. <strong>Methods:</strong> In this phase 1 study,...

詳細記述

書誌詳細
主要な著者:	Ewer (nee Russell), K, Rampling, T, Venkatraman, N, Bowyer, G, Wright, D, Lambe, T, Imoukhuede, E, Payne, R, Fehling, S, Strecker, T, Biedenkopf, N, Krähling, V, Tully, C, Edwards, N, Bentley, E, Samuel, D, Labbe, G, Jin, J, Gibani, M, Minhinnick, A, Wilkie, M, Poulton, I, Lella, N, Roberts, R, Hartnell, F, Bliss, C, Sierra-Davidson, K, Powlson, J, Berrie, E, Tedder, R, Roman, F, Ryck, I, Nicosia, A, Sullivan, N, Stanley, D, Mbaya, O, Ledgerwood, J, Schwartz, R, Siani, L, Colloca, S, Folgori, A, Di Marco, S, Cortese, R, Wright, E, Becker, S, Graham, B, Koup, R, Levine, M, Volkmann, A, Chaplin, P, Pollard, A, Draper, S, Ballou, W, Lawrie, A, Gilbert, S, Hill, A
フォーマット:	Journal article
出版事項:	Massachusetts Medical Society 2016

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA

類似資料